Resumen
OBJETIVOS: Evaluar la concurrencia de las embarazadas con diabetes gestacional (DG) a la reclasificación, determinar cuántas fueron positivas, si éstas tuvieron peores resultados perinatales y si hubo mayor asociación por factores de riesgo (FR) del embarazo en este grupo. MATERIALES y MÉTODOS: Estudio de cohorte retrospectivo de 1183 pacientes con DG asistidas entre 2010-2021. Se realizó glucemia en ayunas posparto (24 horas) y PTOG 75 g a las seis semanas para reclasificación. RESULTADOS: De 1183 pacientes, el 9,97% (118) tuvieron DBT posparto. El resto (1065) fue citado a las seis semanas. Concurrieron 440 (41,3%) y de ellas el 30,4% (134) fueron positivas. La hiperglucemia en ayunas (HGA) de la PTOG diagnóstica del embarazo fue mayor en las positivas (49,2% vs 36,6%, p<0,001). Estas requirieron más insulina (41,7% vs 18,9%, p<0.001) y tuvieron mayor incidencia de hipertensión inducida por el embarazo y preeclampsia. En los resultados perinatales se encontró una mayor internación en unidad de terapia intensiva neonatal en aquellas positivas. DISCUSIÓN: El 41,3% que concurrieron concuerda con la literatura. La HGA (PTOG diagnóstica) y el requerimiento de tratamiento con insulina son los dos FR del embarazo que podrían “predecir” una prueba positiva.
Citas
Organización Mundial de la Salud. Diabetes. Ginebra: OMS; 2016.
American Diabetes Association. Standards of medical care in Diabetes 2022. Diabetes Care 2022 Jan 1; 45 (suppl 1): s232-s243.
Gestational diabetes mellitus. ACOG Practice Bulletin No. 190. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018; 131: e49–64.
Salzberg S, Alvariñas J, Lopez G, Gorbán de Lapertosa S, Linari ME, Falcón E, et al. Guías de diagnóstico y tratamiento de diabetes gestacional. Rev ALAD; 2016 (6):155–169.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998 Jul; 15 (7):539-53
American Diabetes Association. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2021. Diabetes Care; 2021 Jan;44 (1): S200-S 210.
Commendatore V, Faingold C, Fenili C, Frechtel G, González C, Llanos I, et al. Opiniones y recomendaciones de la Sociedad Argentina de Diabetes. Glucemia en ayunas alterada: ¿es oportuno utilizar el punto de corte en 100 mg/dl en Argentina? Revista de la Sociedad Argentina de Diabetes; 2023; Vol. 57(1):9-19.
Organización Mundial de la Salud. Use of Glycated Haemoglobin (HbA 1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Ginebra: Organización Mundial de la Salud; 2011.
Maselli MC, Llanos I, Lucarelli C, Fenili C, Ruibal G, Valdez S. Opiniones y recomendaciones de la Sociedad Argentina de Diabetes Hemoglobina A 1c. Revista de la Sociedad Argentina de Diabetes; 2023; Vol. 57(1):20-23.
American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of Medical Care in diabetes 2022. Diabetes Care;. 2022; 45 (Suppl.1): S 17–S 38
Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract; 2014 Feb; 103(2):176-85.
Eades CE, Cameron DM, Evans JMM. Prevalence of gestational diabetes mellitus in Europe: A meta-analysis. Diabetes Res Clin Pract; 2017 Jul; 129: 173-181
Ministerio de Salud de la Nación. Estadísticas vitales. Información Básica. Ministerio de Salud de la Nación Argentina; 2019. ISSN: 1668-9054 Serie 5 Número 63 Buenos Aires, abril de 2021. Buenos Aires, publicado abril de 2021. www.argentina. gob.ar/salud
Instituto Nacional de Estadística y Censos. Cuarta encuesta Nacional de Factores de Riesgo. Resultados definitivos - Secretaría de Gobierno de Salud de la Nación. Argentina. Octubre 2019. ISBN 978 -950-896-554-7. 4°edición.
Dodd JM, Crowther CA, Antoniou G, Baghurst P, Robinson JS. Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N Z J Obstet Gynaecol; 2007; Aug;47(4):307-12.
HAPO Study Cooperative Research Group, Metzger BE,
Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med; 2008 May 8;358(19):1991-2002
Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta - analysis. BMJ; 2016 Sep 13; 354: i4694.
England LJ, Dietz PM, Njoroge T, Callaghan WM, Bruce C, Buus RM, et al. Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus. Am J Obstet Gynecol; 2009 Apr;200(4): 365.e1-8
Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care; 2002 Oct; 25(10):1862-8
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med, 2005 Jun 16;352(24):2477-86
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and metaanalysis. Lancet, 2009; May 3;373 (9677):1773 -9. doi: 10.1016/S0140-6736(09)60731-5
Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta - analysis. BMJ, 2020 May 13;369:m1361.
Varner MW, Rice MM, Landon MB, Casey BM, Reddy UM, Wapner RJ, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal- Fetal Medicine Units (MFMU) Network. Pregnancies After
the Diagnosis of Mild Gestational Diabetes Mellitus and Risk of Cardiometabolic Disorders. Obstet Gynecol, 2017; Feb;129(2):273 -280; doi: 10.1097/AOG.0000000000001863
Waters TP, Kim SY, Werner E, Dinglas C, Carter EB, Patel R, Sharma AJ, Catalano P. Should women with gestational diabetes be screened at delivery hospitalization for type 2 diabetes? Am J Obstet Gynecol. 2020 Jan;222(1):73e1-73e11. doi: 10.1016/j.ajog.2019.07.035. Epub 2019 Jul 24. PMID: 31351065; PMCID: PMC7206508
Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J, et al. Overweight and the metabolic síndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab. 2009 Jul;94(7):2464-70
Lowe WL Jr, Lowe LP, Kuang A, Catalano PM, Nodzenski M, Talbot O, et al. HAPO Follow-up Study Cooperative Research Group. Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study. Diabetologia. 2019 Apr;62(4):598-610.
Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta - analysis. Diabetologia. 2019 Jun;62(6):905-914.
National Institute for Health and Care Excellence (NICE). Diabetes in pregnancy, Quality standard Published: 19 January 2016, Last updated: 10 January 2023 www.nice.org.uk/guidance/qs 109.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop -Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007 Jul; 30 Suppl 2: S251 -60.
National Institute for Health and Care Excellence (NICE). Diabetes in Pregnancy. Management from preconception to the postnatal period: NICE guideline Published: 25 February 2015 Last updated: 16 December 2020. www.nice.org.uk/guidance/ng3.
Alves JM, Stoll Meier A, Leite IG, Pilger CG, Detsch JC, Radominski RB, et al. Postpartum Reclassification of Glycaemic Status in women with gestational diabetes mellitus and associated risk Factors. Rev Bras Ginecol Obstet. 2016 Aug;38(8):381-90.
Pagotto V, Posadas Martínez ML, Salzberg S, Pochettino PA. Diabetes mellitus gestacional en un hospital de la Ciudad de Buenos Aires, Argentina: incidencia, tratamiento, y frecuencia de tamizaje para reclasificación luego del parto. Revista de la Facultad de Ciencias Médicas de Córdoba. 2022;79(3):248-253
Kwong S, Mitchell RS, Senior PA, Chik CL. Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose vs oral glucose tolerance test. Diabetes Care. 2009 Dec;32(12):2242-4
Jacob Reichelt AA, Ferraz TM, Rocha Oppermann ML, Costa e Forti A, Duncan BB, Fleck Pessoa E, et al. Detecting glucose intolerance after gestational diabetes: inadequacy of fasting glucose alone and risk associated with gestational diabetes and second trimester waist-hip ratio. Diabetologia. 2002 Mar;45(3):455-7
Weinert LS, Mastella LS, Oppermann ML, Silveiro SP, Guimarães LS, Reichelt AJ. Postpartum glucose tolerance status 6 to 12 weeks after gestational diabetes mellitus: a Brazilian cohort. Arq Bras Endocrinol Metabol. 2014 Mar;58(2):197–204
Coustan DR, Carpenter MW, O’Sullivan PS, Carr SR. Gestational diabetes: predictors of subsequent disordered glucosa metabolism. Am J Obstet Gynecol. 1993 Apr; 168(4):1139 -44; discussion 1144-5
Rayanagoudar G, Hashi AA, Zamora J, Khan KS, Hitman GA, Thangaratinam S. Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women. Diabetologia. 2016 Jul;59(7):1403-1411
Schaefer- Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol. 2002 Apr; 186(4):751-6.
Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009 Oct 1;361(14):1339-48
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. on behalf of the American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes -2023. Diabetes Care. 2023 Jan 1;46(Suppl 1): S19 -S40. Erratum in: Diabetes Care. 2023 Feb 01: Erratum in: Diabetes Care. 2023 Sep 1;46(9):1715.
Harper LM, Jauk V, Longo S, Biggio JR, Szychowski JM, Tita AT. Early gestational diabetes screening in obese women: a randomized controlled trial. Am J Obstet Gynecol. 2020 May;222(5):495 e1 - 495.e8